These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8143214)

  • 41. Keratinocytes promote proliferation and inhibit apoptosis of the underlying fibroblasts: an important role in the pathogenesis of keloid.
    Funayama E; Chodon T; Oyama A; Sugihara T
    J Invest Dermatol; 2003 Dec; 121(6):1326-31. PubMed ID: 14675177
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Keloid fibroblasts in culture: abnormal growth behaviour and altered response to the epidermal growth factor.
    Harper RA
    Cell Biol Int Rep; 1989 Apr; 13(4):325-35. PubMed ID: 2786458
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Cicatricial keloids after Waterhouse-Friderichsen syndrome].
    Kahle B; Zilow E; Springer W; Näher H
    Hautarzt; 1994 Feb; 45(2):100-3. PubMed ID: 8150624
    [No Abstract]   [Full Text] [Related]  

  • 44. [The experimental study of intracellular actin in the scar fibroblasts].
    Zhang Q; Cui L; Qian YL
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2000 Sep; 14(5):275-7. PubMed ID: 12516474
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hexose sugars differentially alter collagen gene expression and synthesis in fibroblasts derived from granulation tissue, hypertrophic scar and keloid.
    Kössi J; Vähä-Kreula M; Peltonen J; Risteli J; Laato M
    Arch Dermatol Res; 2004 May; 295(12):521-6. PubMed ID: 15045512
    [TBL] [Abstract][Full Text] [Related]  

  • 46. TGF-beta2 activates proliferative scar fibroblasts.
    Smith P; Mosiello G; Deluca L; Ko F; Maggi S; Robson MC
    J Surg Res; 1999 Apr; 82(2):319-23. PubMed ID: 10090846
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The expression of tenascin-C mRNA in keloids and hypertrophic scars].
    Han CM; He XJ; Ma Q
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2005 Jan; 21(1):40-3. PubMed ID: 15844597
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Hypertrophic scar and keloid].
    Vähä-Kreula M; Peltonen J; Kalimo H; Nieminen S; Niinikoski J; Laato M
    Duodecim; 1995; 111(20):1921-9. PubMed ID: 9841142
    [No Abstract]   [Full Text] [Related]  

  • 49. Expression of basic fibroblast growth factor and its receptor by fibroblast, macrophages and mast cells in hypertrophic scar.
    Akimoto S; Ishikawa O; Iijima C; Miyachi Y
    Eur J Dermatol; 1999; 9(5):357-62. PubMed ID: 10417437
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The effects of beta-aminopropionitrile on the proliferation in cultrured human hypertrophic scar fibroblasts].
    Jin Y; Luo S; Hao X
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2000 May; 16(3):174-6. PubMed ID: 11593698
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Effects of conditioned medium derived from different keratinocytes on proliferation and collagen synthesis of hypertrophic scar fibroblasts].
    Guo S; Zhang L; Wang Z; Liu J
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2002 Mar; 18(2):83-5. PubMed ID: 12192767
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Matrix metalloproteinase-2 and -9 activities in human keloids, hypertrophic and atrophic scars: a pilot study.
    Tanriverdi-Akhisaroglu S; Menderes A; Oktay G
    Cell Biochem Funct; 2009 Mar; 27(2):81-7. PubMed ID: 19165813
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Keloid scars of the head and neck].
    Beogo R; Guiébré YM; Sérémé M; Ouoba K; Zwetyenga N
    Rev Stomatol Chir Maxillofac; 2012 Jun; 113(3):179-83. PubMed ID: 22515916
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Therapeutic problems connected with keloid treatment--new treatment possibilities].
    Brudnik U; Podolec-Rubiś M; Wojas-Pelc A
    Przegl Lek; 2006; 63(9):803-6. PubMed ID: 17479875
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of the potential targets for keloid and hypertrophic scar prevention.
    Zhang L; Qin H; Wu Z; Chen W; Zhang G
    J Dermatolog Treat; 2018 Sep; 29(6):600-605. PubMed ID: 29271272
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Keloids and hypertrophic scars: are they two different sides of the same coin?
    Köse O; Waseem A
    Dermatol Surg; 2008 Mar; 34(3):336-46. PubMed ID: 18177398
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Expression of platelet derived growth factor receptor-beta in fibroblasts of keloid].
    Shang QX; Yuan R; Wang W
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2000 Sep; 14(5):278-82. PubMed ID: 12516475
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The responses of fibroblasts from three parts of keloids and normal skin to interleukin-1 beta and interleukin-6].
    Xu S; Wang Z; Bao W
    Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1998 Jan; 14(1):23-5. PubMed ID: 10452027
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Keloid scars: a case series study].
    Carmassi M; Eraud J; Gonelli D; Magalon G; Andrac Meyer L
    Ann Pathol; 2015 Apr; 35(2):148-53. PubMed ID: 25687786
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gene expression profiles from hypertrophic scar fibroblasts before and after IL-6 stimulation.
    Dasu MR; Hawkins HK; Barrow RE; Xue H; Herndon DN
    J Pathol; 2004 Apr; 202(4):476-85. PubMed ID: 15095275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.